Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
53.1M
-
Shares change
-
+445K
-
Total reported value, excl. options
-
$154M
-
Value change
-
+$875K
-
Put/Call ratio
-
1.81
-
Number of buys
-
43
-
Number of sells
-
-45
-
Price
-
$2.90
Significant Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q3 2025
122 filings reported holding AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK as of Q3 2025.
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.1M shares
of 78.4M outstanding shares and own 67.77% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (8.46M shares), BML Capital Management, LLC (7.47M shares), FMR LLC (5.82M shares), TANG CAPITAL MANAGEMENT LLC (4.83M shares), VANGUARD GROUP INC (4.71M shares), Bain Capital Life Sciences Investors, LLC (2.49M shares), GEODE CAPITAL MANAGEMENT, LLC (1.9M shares), STATE STREET CORP (1.78M shares), DIMENSIONAL FUND ADVISORS LP (1.54M shares), and RENAISSANCE TECHNOLOGIES LLC (1.23M shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.